Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of rPA Anthrax Vaccine (SparVax)
NCT00170456Phase 2Completed
- Sponsor
- PharmAthene
- Start
- Mar 2005
- Primary completion
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of anthrax rPA vaccine in anthrax, sponsored by PharmAthene. Started Mar 2005; status: completed.
02
Drugs
anthrax rPA vaccine
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT00170456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170456.